Vanguard Group
NUVB icon

Vanguard Group’s Nuvation Bio NUVB Stock Holding History

Vanguard Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$139M Buy
15,555,606
+101,011
+0.7% +$626K ﹤0.01% 1719
2025
Q3 		$57.2M Sell
15,454,595
-448,459
-3% -$1.22M ﹤0.01% 2091
2025
Q2 		$31M Buy
15,903,054
+505,234
+3% +$1.05M ﹤0.01% 2348
2025
Q1 		$27.1M Sell
15,397,820
-334,747
-2% -$762K ﹤0.01% 2363
2024
Q4 		$41.8M Buy
15,732,567
+4,913,820
+45% +$12.7M ﹤0.01% 2239
2024
Q3 		$24.8M Buy
10,818,747
+675,849
+7% +$2.06M ﹤0.01% 2486
2024
Q2 		$29.6M Buy
10,142,898
+2,608,750
+35% +$7.96M ﹤0.01% 2370
2024
Q1 		$27.4M Buy
7,534,148
+219,533
+3% +$422K ﹤0.01% 2441
2023
Q4 		$11M Buy
7,314,615
+18,457
+0.3% +$23.8K ﹤0.01% 2891
2023
Q3 		$9.78M Buy
7,296,158
+17,118
+0.2% +$28.5K ﹤0.01% 2896
2023
Q2 		$13.1M Buy
7,279,040
+76,574
+1% +$130K ﹤0.01% 2797
2023
Q1 		$12M Sell
7,202,466
-2,729,975
-27% -$5.53M ﹤0.01% 2845
2022
Q4 		$19.1M Sell
9,932,441
-2,712,010
-21% -$5.49M ﹤0.01% 2650
2022
Q3 		$28.3M Buy
12,644,451
+11,813
+0.1% +$33.7K ﹤0.01% 2471
2022
Q2 		$40.9M Sell
12,632,638
-299,822
-2% -$1.31M ﹤0.01% 2290
2022
Q1 		$68M Buy
12,932,460
+1,671,908
+15% +$9.39M ﹤0.01% 2144
2021
Q4 		$95.7M Sell
11,260,552
-641,975
-5% -$5.9M ﹤0.01% 2007
2021
Q3 		$118M Buy
11,902,527
+806,166
+7% +$7.31M ﹤0.01% 1901
2021
Q2 		$103M Buy
11,096,361
+4,139,205
+59% +$47.2M ﹤0.01% 1984
2021
Q1 		$72.7M Buy
+6,957,156
New +$77.8M ﹤0.01% 2116

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Group's NUVB Position: Q4 2025 in Review

Vanguard Group increased its Nuvation Bio (NUVB) stake by 0.65% in Q4 2025, buying an estimated $626K and bringing the position to 15,555,606 shares worth $139M. The position accounts for ﹤0.01% of the portfolio, ranked #1719.

Vanguard Group first reported a position in NUVB in Q1 2021 and has held it in 20 quarters since. 223 funds tracked by Wall St. Rank hold NUVB as of Q4 2025.

  • Vanguard Group held 15,555,606 shares of Nuvation Bio worth $139M as of Q4 2025.
  • Vanguard Group bought 101,011 Nuvation Bio shares in Q4 2025, an estimated $626K.
  • Nuvation Bio made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1719 holding.
  • Vanguard Group first reported a position in Nuvation Bio in Q1 2021 and has held it in 20 quarters since.
  • 223 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.